Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis Inc (NASDAQ: ACB) rallied more than 25% this morning after President Trump endorsed cannabidiol (CBD) as potential breakthrough in senior healthcare. In a social media post over the ...

Shares of Aurora Cannabis ACB have risen 21% year to date, outperforming the industry’s 5% rise, as seen in the chart below.

Aurora Cannabis remains a bullish opportunity due to its cheap valuation and an improving business model, despite recent stock weakness. International medical cannabis sales are growing, especially in ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Aurora Cannabis ACB is slated to release first-quarter fiscal 2026 results on Aug. 6, before market open. The Zacks Consensus Estimate for earnings and revenues is pegged at 18 cents per share and $70 ...

Aurora Cannabis (NASDAQ:ACB) traded higher on Thursday after the company expanded the eligibility for its compassionate pricing program in Canada in a bid to widen access to its medical cannabis ...

Aurora Cannabis Inc. closed 29.38% below its 52-week high of $6.91, which the company reached on February 10th.

Aurora Cannabis Inc. closed 25.62% below its 52-week high of $6.91, which the company reached on February 10th.